Dimensional Fund Advisors
MRSN

Dimensional Fund Advisors’s Mersana Therapeutics MRSN Stock Holding History

Dimensional Fund Advisors’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-548
Closed -$27.5K – 3369
2024
Q2 		$27.5K Sell
548
-702
-56% -$50.8K ﹤0.01% 3341
2024
Q1 		$140K Sell
1,250
-2,817
-69% -$280K ﹤0.01% 3225
2023
Q4 		$236K Sell
4,067
-422
-9% -$17K ﹤0.01% 3168
2023
Q3 		$143K Sell
4,489
-3,095
-41% -$147K ﹤0.01% 3273
2023
Q2 		$624K Sell
7,584
-9,189
-55% -$1.34M ﹤0.01% 3016
2023
Q1 		$1.72M Buy
+16,773
New +$2.35M ﹤0.01% 2772
2022
Q3 		$3.33M Buy
19,700
+11,338
+136% +$1.84M ﹤0.01% 2559
2022
Q2 		$965K Buy
8,362
+920
+12% +$86.5K ﹤0.01% 2924
2022
Q1 		$742K Sell
7,442
-339
-4% -$39.6K ﹤0.01% 3062
2021
Q4 		$1.21M Buy
7,781
+280
+4% +$54.5K ﹤0.01% 2980
2021
Q3 		$1.77M Buy
7,501
+461
+7% +$135K ﹤0.01% 2888
2021
Q2 		$2.39M Sell
7,040
-114
-2% -$43.2K ﹤0.01% 2822
2021
Q1 		$2.89M Sell
7,154
-128
-2% -$62.1K ﹤0.01% 2753
2020
Q4 		$4.84M Sell
7,282
-527
-7% -$293K ﹤0.01% 2542
2020
Q3 		$3.63M Sell
7,809
-155
-2% -$78.3K ﹤0.01% 2555
2020
Q2 		$4.66M Sell
7,964
-81
-1% -$27.7K ﹤0.01% 2500
2020
Q1 		$1.17M Buy
8,045
+4,026
+100% +$704K ﹤0.01% 2853
2019
Q4 		$576K Buy
4,019
+1,527
+61% +$112K ﹤0.01% 3114
2019
Q3 		$98K Buy
2,492
+1,155
+86% +$84K ﹤0.01% 3345
2019
Q2 		$135K Buy
+1,337
New +$157K ﹤0.01% 3364

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors's MRSN Position: Q3 2024 in Review

Dimensional Fund Advisors sold out of Mersana Therapeutics (MRSN) in Q3 2024, closing a stake of 548 shares — an estimated $27.5K sold.

Dimensional Fund Advisors first reported a position in MRSN in Q2 2019 and held it in 20 quarters. The position peaked at $4.84M in Q4 2020. 113 funds tracked by Wall St. Rank hold MRSN as of Q3 2024.

  • Dimensional Fund Advisors reported no remaining Mersana Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 548 Mersana Therapeutics shares in Q3 2024, an estimated $27.5K.
  • Dimensional Fund Advisors first reported a position in Mersana Therapeutics in Q2 2019 and held it in 20 quarters.
  • Dimensional Fund Advisors's Mersana Therapeutics position peaked at $4.84M in Q4 2020.
  • 113 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q3 2024.

Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.